Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance
Achieve your weight-loss goals with the right treatment. We offer weight-loss injections such as compounded GLP-1 alternatives as deemed clinically necessary by a licensed provider. The best option will be determined based on your health needs to help you achieve your weight-loss goals.






Wegovy® is now available as a once-daily pill, offering a needle-free option for people who prefer oral medication. Like the Wegovy® pen, the pill contains semaglutide and is FDA-approved for chronic weight management.
This new delivery method gives patients more flexibility in how they take Wegovy®, while still receiving provider-guided care through Shed.

*In clinical trials of Wegovy® (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise. This compares to approximately 2–3% weight loss with diet and exercise alone.















Compounded medications are prepared by licensed pharmacies to meet the specific needs of individual patients. These medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. However, they are made in accordance with strict regulatory guidelines. If your clinician determines that a compounded medication is clinically appropriate for you, please be aware that it is not an FDA-approved product.
Ozempic®, Wegovy®, and Rybelsus® are the only FDA-approved products containing semaglutide produced by Novo Nordisk, Inc., while Zepbound® and Mounjaro® are the only FDA-approved products containing tirzepatide produced by Lilly USA LLC.




Achieve your weight-loss goals with the right treatment. We offer weight-loss injections such as compounded GLP-1 alternatives as deemed clinically necessary by a licensed provider. The best option will be determined based on your health needs to help you achieve your weight-loss goals.




Achieve your weight-loss goals with the right treatment. We offer weight-loss injections such as compounded GLP-1 alternatives as deemed clinically necessary by a licensed provider. The best option will be determined based on your health needs to help you achieve your weight-loss goals.







Doctor of Medicine (MD),
Internal Medicine Physician
While GLP-1 microdosing is ideal for maintenance, longevity, and overall wellness support, those with a significant weight-loss goal may be better suited for a standard GLP-1 dose.

Compounded medications are prepared by licensed pharmacies to meet the specific needs of individual patients. These medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. However, they are made in accordance with strict regulatory guidelines. If your clinician determines that a compounded medication is clinically appropriate for you, please be aware that it is not an FDA-approved product.
Ozempic®, Wegovy®, and Rybelsus® are the only FDA-approved products containing semaglutide produced by Novo Nordisk, Inc., while Zepbound® and Mounjaro® are the only FDA-approved products containing tirzepatide produced by Lilly USA LLC.
Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance